CASP3 and neoplasm: The current study further validates 18F-ICMT-11 as a caspase-3-specific PET radiotracer in a doxycycline-inducible death-switch tumour model with the conditional activation of caspase-3, without the potentially complex effects of anti-cancer therapeutics [28].